Christophe Deroose
Universitaire Ziekenhuizen Leuven
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Christophe Deroose.
Breathe | 2018
Charlotte Van de Kerkhove; Walter De Wever; Eric Verbeken; Christophe Deroose; Kris Nackaerts
A 66-year-old, male patient with a 10-pack-year history of smoking was referred to the internal medicine consultation because of a 4-week history of fatigue, weakness, intermittent low-grade fever, appetite and weight loss, and a mild dry cough. His previous history was unremarkable and his physical examination was normal. Routine laboratory screening revealed leukocytosis (11.08×109 leukocytes per L), elevated C-reactive protein (72.1u2005mg⋅L−1) and erythrocyte sedimentation rate 57u2005mm⋅h−1. Analyses for rheumatoid factor, antinuclear antibodies, and cytoplasmic and perinuclear anti-neutrophil cytoplasmic antibodies were all negative. Pulmonary function tests (static and dynamic volumes, flow–volume curve, and lung diffusion capacity) were within the predictive values. Chest radiography demonstrated bilateral hilar enlargement. The patient subsequently underwent a computed tomography (CT) scan of the chest (figure 1). Beware unusual presentations of more common disease entities, as in this interactive case report http://ow.ly/qj7f30eVFsp
Acta Chirurgica Belgica | 2017
Karel Demey; Hans Van Veer; Philippe Nafteux; Christophe Deroose; Karin Haustermans; Johan Coolen; Vincent Vandecaveye; Willy Coosemans; Eric Van Cutsem
Abstract Introduction: A new hypermetabolic lesion on 18FDG-PET/CT after neo-adjuvant chemoradiotherapy for distal esophageal cancer can be a hepatic metastasis and should be examined carefully before esophagectomy. Case-report: We present a case of acute and nodular radiation-induced injury of the left liver after neo-adjuvant chemoradiotherapy for distal esophageal cancer, which resembles a hepatic metastasis on 18FDG-PET/CT. Acute and nodular radiation hepatitis (RH) can be a potential cause of false-positive findings of malignancy and therefore exclude patients who could benefit from esophagectomy. Conclusion: 18FDG-PET/CT images should therefore carefully be interpreted and compared with the radiation beams, dose distribution and eventually clarified by DW-MR imaging.
Radiotherapy & Oncology Journal | 2016
Angela Botticella; G. Defraene; Charlotte Billiet; C. Draulans; Kristiaan Nackaerts; Christophe Deroose; Johan Coolen; Philippe Nafteux; Stéphanie Peeters; Dirk De Ruysscher
Radiotherapy & Oncology Journal | 2016
Angela Botticella; G. Defraene; Kristiaan Nackaerts; Christophe Deroose; Philippe Nafteux; Stéphanie Peeters; Dirk De Ruysscher
Archive | 2016
Bryan Holvoet; Mattia Quattrocelli; Sarah Belderbos; Lore Pollaris; Esther Wolfs; Olivier Gheysens; Rik Gijsbers; Jeroen Vanoirbeek; Catherine M. Verfaillie; Maurilio Sampaolesi; Christophe Deroose
Archive | 2016
Ines Joye; Annelies Debucquoy; Albert Wolthuis; André D'Hoore; Eric Van Cutsem; Vincent Vandecaveye; Xavier Sagaert; Christophe Deroose; Karin Haustermans
Archive | 2016
K. Geboes; Eric Van Cutsem; Raymond Aerts; Ivan Borbath; Saskia Carton; Karin Dahan; Etienne Danse; Thierry Delaunoit; Pieter Demetter; Christophe Deroose; Damien Dresse; P Flamen; Kristiaan Nackaerts; Bart Op de Beeck; Geert Roeyen; Frank Timmermans; Brigitte Velkeniers; Chris Verslype
Archive | 2015
Bryan Holvoet; Sarah Belderbos; Mattia Quattrocelli; Lore Pollaris; Esther Wolfs; Olivier Gheysens; Rik Gijsbers; Jeroen Vanoirbeek; Catherine M. Verfaillie; Maurilio Sampaolesi; Christophe Deroose
Archive | 2015
Jafargholi Rangraz; Kristof Baete; Geert Maleux; Christophe Deroose; Johan Nuyts
Archive | 2015
Bryan Holvoet; Sarah Belderbos; Mattia Quattrocelli; Lore Pollaris; Esther Wolfs; Olivier Gheysens; Rik Gijsbers; Jeroen Vanoirbeek; Catherine M. Verfaillie; Maurilio Sampaolesi; Christophe Deroose